Saravanan, S., Madhavan, V., Balakrishnan, P., Smith, D. M., Solomon, S. S., Sivamalar, S., . . . Kantor, R. (2013). Darunavir Is a Good Third-Line Antiretroviral Agent for HIV Type 1-Infected Patients Failing Second-Line Protease Inhibitor-Based Regimens in South India. Mary Ann Liebert, Inc.
Citação norma ChicagoSaravanan, Shanmugam, et al. Darunavir Is a Good Third-Line Antiretroviral Agent for HIV Type 1-Infected Patients Failing Second-Line Protease Inhibitor-Based Regimens in South India. Mary Ann Liebert, Inc, 2013.
Citação norma MLASaravanan, Shanmugam, et al. Darunavir Is a Good Third-Line Antiretroviral Agent for HIV Type 1-Infected Patients Failing Second-Line Protease Inhibitor-Based Regimens in South India. Mary Ann Liebert, Inc, 2013.